Product References — Single Donor Human Complement Serum

Human Complement Serum - May 31, 2017

Posted by Leanne Kodsman on

May 31, 2017 Innovative Research's Single Donor Human Complement Serum was recently used in the following study: Bystander mechanism for complement-initiated early oligodendrocyte injury in neuromyelitis opticaLukmanee Tradtrantip, Xiaoming Yao, Tao Su, Alex J. Smith, Alan S. Verkman - Acta Neuropathologica, 2017 ... Complement dependent cytotoxicity Specified concentrations of AQP4-IgG (or control human IgG, Thermo Fisher Scientific, Rockford, IL) and human complement (Innovative Research, Novi, MI) were added in Hank's buffer, and cells were incubated at 37 °C for specified times. ...

Read more →

Single Donor Human Complement Serum Reference 4-22-15

Posted by Leanne Kodsman on

Innovative Research's Single Donor Human Complement Serum was recently used in the following study: An AntiC1s Monoclonal, TNT003, Inhibits Complement Activation Induced by Antibodies Against HLAKA Thomas, NM Valenzuela, D Gjertson, A Mulder - American Journal of , 2015 Single donor normal human serum (NHS) was used as source of active complement (IPLA-CSERS; Innovative Research, Novi, MI). Monoclonal and polyclonal antibody sources. HLA-Ab came from two main sources...

Read more →

Pooled Complement Human Serum Reference 6-28-14

Posted by Leanne Kodsman on

Innovative Research's Pooled Complement Human Serum was recently used in the following study: Inhibitor (s) of the classical complement pathway in mouse serum limit the utility of mice as experimental models of neuromyelitis opticaJ Ratelade, AS Verkman - Molecular Immunology, 2014We conclude that mice have limited utility as models of NMO. 2. Materials and methods. 2.1. Reagents and antibodies. Complement/sera from mouse (CD1 and C57BL/6 strains), rat (Wistar strain), guinea pig and human were purchased from Innovative Research (Novi, MI).

Read more →